Wenzhou Medical University and collaborating institutions have identified a population of human neural retinal stem-like cells able to regenerate retinal tissue and support visual recovery. Vision ...

Nanoscope Therapeutics Inc., a biotechnology company focused on developing and commercializing novel, disease‑agnostic therapies for patients with photoreceptor loss and vision impairment due to ...

During retinal development, Setd8 safeguards chromatin accessibility through the histone marker H4K20me1. When Setd8 is present (right), genes required for retinal progenitor cell maintenance and DNA ...

A hybrid retinal implant using stem-cell-derived neurons and microelectrodes lowers activation thresholds and improves signal precision, offering a more natural interface for high-resolution vision ...

Somewhere around 200 million people worldwide live with age-related macular degeneration, and for those with the dry form of ...

Researchers at the University of Bristol, together with collaborators at London’s Global University Institute of Ophthalmology, and the University of Bristol spin-out Cirrus Therapeutics, have ...

Cell replacement therapy offers new hope for millions of people affected by retinal degenerations (RDs)—a group of blinding conditions caused by the loss of light-sensing photoreceptor cells in the ...

Inside the human eye, the retina is made up of several types of cells, including the light-sensing photoreceptors that initiate the cascade of events that lead to vision. Damage to the photoreceptors, ...

The retina is a thin layer of neural tissue at the back of the eye that detects light and converts it into signals, sent to the brain. During development, all the specialized neurons in the ...